<DOC>
	<DOCNO>NCT02466048</DOCNO>
	<brief_summary>This study design investigate safety efficacy SurgiFill™ , bone graft material , patient spinal fusion .</brief_summary>
	<brief_title>Efficacy Safety SurgiFill™ Spinal Fusion</brief_title>
	<detailed_description>This study open-trial study . The study explain subject voluntarily agree participate . Their eligibility participate study check , either right leave side one patient select study group , , control group , randomization . In area study group , autogenous bone SurgiFillTM graft ; area control group , autogenous bone graft . They ask follow guideline investigator study visit hospital seven time , include screening . At visit , subject undergo examination doctor , CT scan , X-ray , SPECT/CT procedure evaluate safety efficacy SurgiFill™ . ( *If subject get surgery screening date , total number visit six ) .</detailed_description>
	<criteria>1 . Patients require spinal fusion 2 . Adult patient age 20 old 3 . Patients voluntarily agree participate study sign informed consent form , fall exclusion criterion 1 . Patients family member history , ongoing , autoimmune disease 2 . Patients history anaphylactic response 3 . Patients hypersensitivity graft material 4 . Patients hypersensitivity pig protein 5 . Patients osteomyelitis surgery area 6 . Patients pregnant , breastfeeding , plan become pregnant 7 . Patients tumor noncurable disease 8 . Patients history radiation therapy cancer treatment within two year ( Those show normal insignificant test result may enrol study receive SurgiFill™ injection base investigator 's judgment . ) 9 . Patients diabetes ( Those maintain normal blood sugar level develop complication may receive SurgiFill™ injection base investigator 's judgment , doctor 's confirmation require . ) 10 . Patients infection require hospitalization antibiotic administration antiseptic agent 11 . Patients undergo adrenocortical hormone therapy ( Those show normal insignificant test result may enrol study receive SurgiFill™ injection base investigator 's judgment . ) 12 . Patients liver , heart , kidney disease ( Those show normal insignificant test result may enrol study receive SurgiFill™ injection base investigator 's judgment . Hypertension patient allow . ) 13 . Patients infected virus ( Those show normal insignificant test result may enrol study receive SurgiFill™ injection base investigator 's judgment . ) 14 . Patients chronic renal failure endocrine system disease ( Those show normal insignificant test result may enrol study receive SurgiFill™ injection base investigator 's judgment . ) 15 . Patients consider inappropriate participation study due condition ( e.g. , mental illness ) base investigator 's judgment 16 . Patients participate another clinical trial ( limited participate study fracture within last six month . )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>spinal fusion</keyword>
	<keyword>bone graft</keyword>
	<keyword>collagen</keyword>
</DOC>